| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 469,1 k € | +16.8% | 401,6 k € | +15.5% | 347,7 k € | +11.4% | 312,2 k € | -1.0% | 315,3 k € | +14.7% | 274,9 k € | +3.0% | 266,8 k € | +128.8% | 116,6 k € | -47.9% | 224,0 k € | +11.8% | 200,4 k € | +1.1% | 198,2 k € | +1.0% | 196,3 k € | -3.3% | 203,1 k € | +11.9% | 181,5 k € | +18.2% | 153,7 k € | +38.7% | 110,8 k € | -13.1% | 127,5 k € | +15.0% | 110,9 k € | +11.7% | 99,3 k € | -4.6% | 104,1 k € | |
| EBITDA | 446,0 k € | +17.8% | 378,6 k € | +19.3% | 317,2 k € | +8.8% | 291,7 k € | -0.4% | 292,8 k € | +17.5% | 249,2 k € | +1.9% | 244,6 k € | +154.8% | 96,0 k € | -52.1% | 200,4 k € | +18.6% | 168,9 k € | -7.5% | 182,7 k € | -1.5% | 185,5 k € | -1.4% | 188,2 k € | +5.9% | 177,7 k € | +18.9% | 149,5 k € | +45.3% | 102,9 k € | -18.4% | 126,0 k € | +15.1% | 109,4 k € | +12.2% | 97,5 k € | -2.3% | 99,8 k € | |
| Operating profit | 377,6 k € | +16.7% | 323,4 k € | +23.5% | 261,9 k € | +11.8% | 234,3 k € | -3.7% | 243,3 k € | +25.1% | 194,4 k € | +2.5% | 189,7 k € | +350.0% | 42,2 k € | -70.9% | 145,0 k € | +24.7% | 116,3 k € | -21.6% | 148,4 k € | +19.7% | 124,0 k € | -13.3% | 143,0 k € | +15.9% | 123,4 k € | +29.6% | 95,2 k € | +25.7% | 75,7 k € | +9.8% | 69,0 k € | +31.6% | 52,4 k € | +27.2% | 41,2 k € | -8.2% | 44,9 k € | |
| Profit/loss | 228,0 k € | -16.8% | 274,0 k € | +3.0% | 266,0 k € | +58.8% | 167,5 k € | -4.1% | 174,6 k € | -22.9% | 226,5 k € | +77.8% | 127,4 k € | +367.0% | 27,3 k € | -70.4% | 92,2 k € | +10.7% | 83,3 k € | -22.2% | 107,0 k € | +22.5% | 87,3 k € | -33.2% | 130,6 k € | +25.6% | 104,0 k € | +76.0% | 59,1 k € | +47.0% | 40,2 k € | +0.6% | 40,0 k € | +52.2% | 26,3 k € | +47.4% | 17,8 k € | -9.8% | 19,7 k € | |
| Equity | 1,3 M € | +8.1% | 1,2 M € | -51.8% | 2,6 M € | +11.5% | 2,3 M € | +7.8% | 2,1 M € | +8.8% | 2,0 M € | +13.0% | 1,7 M € | +7.9% | 1,6 M € | +1.7% | 1,6 M € | +6.1% | 1,5 M € | +5.9% | 1,4 M € | +8.2% | 1,3 M € | +7.1% | 1,2 M € | +12.0% | 1,1 M € | -2.7% | 1,1 M € | +587.2% | 163,3 k € | +32.6% | 123,2 k € | +48.0% | 83,2 k € | +46.1% | 56,9 k € | +45.5% | 39,1 k € | |
| Total assets | 2,2 M € | +6.1% | 2,1 M € | -22.6% | 2,7 M € | +10.1% | 2,4 M € | +6.5% | 2,3 M € | +8.1% | 2,1 M € | +12.3% | 1,9 M € | +7.1% | 1,8 M € | -1.4% | 1,8 M € | +5.3% | 1,7 M € | +6.2% | 1,6 M € | +2.6% | 1,6 M € | +15.8% | 1,3 M € | +8.7% | 1,2 M € | -6.1% | 1,3 M € | +262.5% | 364,0 k € | +54.9% | 234,9 k € | +10.8% | 212,0 k € | +1.9% | 208,0 k € | -8.7% | 228,0 k € | |
| Cash | 336,8 k € | +119.4% | 153,5 k € | -62.1% | 405,1 k € | -41.8% | 696,4 k € | +8.5% | 642,0 k € | +28.5% | 499,6 k € | +38.0% | 362,0 k € | +57.4% | 230,0 k € | -18.9% | 283,7 k € | +71.0% | 165,9 k € | -30.4% | 238,4 k € | +15.7% | 206,0 k € | +393.3% | 41,8 k € | -64.6% | 117,9 k € | +283.8% | 30,7 k € | -49.3% | 60,5 k € | -11.0% | 68,0 k € | +8.8% | 62,5 k € | -6.6% | 66,9 k € | +142.7% | 27,6 k € | |
| Debts | 862,8 k € | +3.3% | 835,2 k € | +690.8% | 105,6 k € | -15.4% | 124,9 k € | -13.6% | 144,5 k € | -2.0% | 147,5 k € | +3.8% | 142,1 k € | -1.2% | 143,8 k € | -26.5% | 195,7 k € | -1.2% | 198,0 k € | +8.4% | 182,6 k € | -26.7% | 249,2 k € | +100.7% | 124,2 k € | -11.6% | 140,5 k € | -28.7% | 197,0 k € | -1.8% | 200,7 k € | +79.5% | 111,8 k € | -13.2% | 128,8 k € | -14.8% | 151,1 k € | -20.0% | 188,8 k € | |
| Staff | — | — | — | — | — | — | — | — | — | — | 0,3 | 0,3 | 0,3 | 0,3 | — | — | — | — | — | — | ||||||||||||||||||||
Private limited company · Mol · incorporated on 05/04/2000
Private limited company profitable and well capitalised. Cash position rising (+119.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. MARC SMETS is a Private limited company incorporated in 2000. Its main activity is: General medical practice activities. Its registered office is in Mol.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette